Tharimmune
Healthcare
$540M
Raised
1
Rounds
Tharimmune is a healthcare project focused on developing innovative immunotherapies to treat various diseases. The project aims to harness the power of the immune system to improve patient outcomes and enhance existing treatment protocols.
Rounds
| Category | Round | Amount | Date | Investors |
|---|---|---|---|---|
| Healthcare | Post-IPO | $540M | Nov 4, 2025 |  Liberty City Ventures DRW Venture Capital Kraken+7 more |
Tradeweb
Nima Capital
Polychain Capital
7RIDGE
ARK Invest
Canton Foundation
Broadridge